
Sign up to save your podcasts
Or


Why rely on one method when three are better? Ezra CEO Emi Gal explains how combining imaging, liquid biopsy, and biomarkers creates a superior cancer screening protocol. He also shares how AI enables longitudinal tracking of lesions, reducing false positives and patient anxiety. Learn what makes Ezra’s approach uniquely effective in the fight against cancer.
By Tensor Black4.3
1414 ratings
Why rely on one method when three are better? Ezra CEO Emi Gal explains how combining imaging, liquid biopsy, and biomarkers creates a superior cancer screening protocol. He also shares how AI enables longitudinal tracking of lesions, reducing false positives and patient anxiety. Learn what makes Ezra’s approach uniquely effective in the fight against cancer.

4,362 Listeners

21,237 Listeners

2,082 Listeners

112,356 Listeners

8,453 Listeners

4,058 Listeners

9,280 Listeners

8,190 Listeners

6,056 Listeners

805 Listeners

29,158 Listeners

531 Listeners

1,193 Listeners

558 Listeners

3,098 Listeners